Filters
![]() |
|
| |||
859 of 859 products, sorted A-Z
|
2.5 ★★ (6)★ ☆ ☆☆ |
Tokyo Smoke |
THC | 180 - 240mg/g (21%) | THC MEDIUM | 0 - 10mg/g (0.5%) | CBD |
eweed.pro | SATIVA | csmeter © |
$ –.– – ![]() |
3.5g | $0.00/g |
![]() |
Citrus 4/10 |
AROMA / FLVR |
|
+Spice 4 |
+Woody 4 |
![]() |
Anxiety 6/10 |
AID** WITH |
|
+Pain 5 |
+Energy 4 |
Potency | THC Medium | |
THC | 180-240mg/g | 21% |
CBD | 0-10mg/g | 0.5% |
Plant | Sativa Dominant | |
Strain(s) | Blue Dream | |
Grown In | Ontario | |
Method | INDOOR | |
Producer | Tokyo Smoke by Canopy Growth Corp. | |
GTIN# |
00886708001644 (3.5g) 00886708001651 (7g) |
|
Terpenesⓘ
|
Beta-Caryophyllene, Beta-Pinene, Humulene, Limonene, Myrcene |
Rise dried flower by Tokyo Smok is a sativa dominant strain with strong THC potency, grown in a hybrid greenhouse where it's machine-trimmed, hand-groomed and dried using the rack and tray method. The strain's lemon-pine flavour comes from a terpene mixture highlighted by limonene (also found in citrus fruits and juniper) and linalool (which it shares with lavender, mint and cinnamon). Available in various sizes of dried flower and pre-rolled.
Tokyo Smoke is an award-winning, design-focused company that seamlessly blends the best of cannabis with preeminent retail. Tokyo Smoke is ushering in a new era with an elevated and immersive retail experience featuring it’s signature collection of accessories and line of recreational cannabis.
About Canopy Growth
Our vision is to be the number one cannabis company in the world. From product and process innovation to market execution and everything in between, we are driven by a passion for leadership, a commitment to drive the industry forward, and above all else, providing medical and recreational cannabis consumers the best possible experience.
With operations spanning fifteen countries across five continents, Canopy Growth Corporation is a world-leading diversified cannabis company proudly dedicated to educating healthcare practitioners, advancing the public discourse surrounding cannabis, and conducting robust clinical research in cannabinoid-based animal and human medicines.
2.0 ★★ ☆☆☆ |
Arkadi | May-23 |
1.0 ★ ☆☆☆☆ |
Kathy | Oct-22 |
1.0 ★ ☆☆☆☆ |
Marty | Jun-22 |
1.0 ★ ☆☆☆☆ |
Daniel | Apr-22 |
5.0 ★★★★★ |
Richard | Feb-22 |